Raub Brock Capital Management LP has filed its 13F form on January 15, 2026 for Q4 2025 where it was disclosed a total value porftolio of $437 Million distributed in 40 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Barclays with a value of $75.8M, Taiwan Semiconductor Manufacturing CO LTD with a value of $26.3M, Parker Hannifin Corp with a value of $23.2M, Eli Lilly & CO with a value of $21.6M, and Abb Vie Inc. with a value of $20.9M.

Examining the 13F form we can see an decrease of $27.4M in the current position value, from $465M to 437M.

Below you can find more details about Raub Brock Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $437 Million
ETFs: $128 Million
Technology: $96.1 Million
Industrials: $71.3 Million
Healthcare: $53.9 Million
Financial Services: $51.3 Million
Consumer Cyclical: $18.7 Million
Basic Materials: $16.7 Million
Communication Services: $1.2 Million
Other: $204,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 40
  • Current Value $437 Million
  • Prior Value $465 Million
  • Filing
  • Period Q4 2025
  • Filing Date January 15, 2026
  • Form Type 13F-HR
  • Activity in Q4 2025
  • New Purchases 1 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 27 stocks
Track This Portfolio

Track Raub Brock Capital Management LP Portfolio

Follow Raub Brock Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raub Brock Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Raub Brock Capital Management LP with notifications on news.